X T L Biopharmaceuticals reported 289K in Sales Revenues for its fiscal quarter ending in December of 2024.


Sales Change Date
Alaunos Therapeutics USD 0 4K Sep/2024
Bioline Rx USD 304K 4.64M Jun/2025
Teva Pharmaceutical Industries USD 14.06B 0 Jun/2025
X T L Biopharmaceuticals 289K 127K Dec/2024